Cathepsin-D, a lysosomal aspartyl proteinase, is highly secreted by breast
cancer cells and its over-expression by transfection stimulates cancer cell
proliferation. The mechanism by which this protease affects proliferation
remains, however, unknown. In order to determine whether proteolytic activi
ty is necessary, we abolished its enzymatic activity using site-directed mu
tagenesis followed by stable transfection in 3Y1-Ad12 cancer cells. Substit
ution of the aspartic acid residue 231 by an asparagine residue in its cata
lytic site abrogated the cathepsin-D proteolytic activity but did not affec
t its expression level, processing or secretion. However, like wild-type ca
thepsin-D, this mutated catalytically-inactive cathepsin-D retained its cap
acity to stimulate proliferation of cells embedded in Matrigel or collagen
I matrices, colony formation in soft agar and tumor growth in athymic nude
mice. Addition on the mock-transfected cells, of either conditioned media c
ontaining the wild-ty pe or the mutated pro-cathepsin-D, or of the purified
mutated pro-cathepsin-D, partially mimicked the mitogenic activity of the
transfected cathepsin-D, indicating a role of the secreted pro-enzyme. More
over, addition of two anti-cathepsin-D antibodies on the cathepsin-D transf
ected cells inhibited their proliferation, suggesting an action of the secr
eted pro-cathepsin-D via an autocrine loop. A synthetic peptide containing
the 27-44 residue moiety of the cathepsin-D pro-fragment was, however, not
mitogenic suggesting that a receptor for the pro-fragment was not involved.
Furthermore, the cathepsin-D mitogenicity was not blocked by inhibiting th
e interaction of pro-cathepsin-D with the mannose-6-phosphate receptors. Ou
r results altogether demonstrate that a mutated cathepsin-D devoid of catal
ytic activity is still mitogenic and suggest that it is acting extracellula
rly by triggering directly or indirectly a yet unidentified cell surface re
ceptor.